Loading...
Dernières publications
-
Dylan Moutachi, Janek Hyzewicz, Pauline Roy, Mégane Lemaitre, Damien Bachasson, et al.. Treadmill running and mechanical overloading improved the strength of the plantaris muscle in the dystrophin‐desmin double knockout (DKO) mouse. The Journal of Physiology, In press, ⟨10.1113/JP286425⟩. ⟨hal-04643936⟩
-
Medhi Hassani, Dylan Moutachi, Mégane Lemaitre, Alexis Boulinguiez, Denis Furling, et al.. Beneficial effects of resistance training on both mild and severe mouse dystrophic muscle function as a preclinical option for Duchenne muscular dystrophy. PLoS ONE, 2024, 19, ⟨10.1371/journal.pone.0295700⟩. ⟨hal-04501283⟩
-
Antonio Atalaia, Dagmar Wandrei, Nawel Lalout, Rachel Thompson, Adrian Tassoni, et al.. EURO-NMD registry: federated FAIR infrastructure, innovative technologies and concepts of a patient-centred registry for rare neuromuscular disorders. Orphanet Journal of Rare Diseases, 2024, 19 (1), pp.66. ⟨10.1186/s13023-024-03059-3⟩. ⟨hal-04460667⟩
-
Florent Porquet, Lin Weidong, Kévin Jehasse, Hélène Gazon, Maria Kondili, et al.. Specific DMPK-promoter targeting by CRISPRi reverses myotonic dystrophy type 1-associated defects in patient muscle cells. Molecular Therapy - Nucleic Acids, 2023, 32, pp.857 - 871. ⟨10.1016/j.omtn.2023.05.007⟩. ⟨hal-04287597⟩
-
Caroline Le Guiner, T Larcher, A Lafoux, G Toumaniantz, S Webb, et al.. Characterization of the muscular and cardiac diseases of the DMSXL mouse model, a transgenic mouse model for Myotonic Dystrophy type 1. American Society of Gene & Cell Therapy, May 2023, LOS ANGELES, United States. ⟨hal-04096181⟩
-
Dylan Moutachi, Mégane Lemaitre, Clément Delacroix, Onnik Agbulut, Denis Furling, et al.. Valproic acid reduces muscle susceptibility to contraction‐induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy. Clinical and Experimental Pharmacology and Physiology, In press, ⟨10.1111/1440-1681.13804⟩. ⟨hal-04146953⟩
Chiffres clés
136
Publications avec texte intégral
Open Access
53 %
Mots clés
Aging
RNA biology
Antisense oligonucleotide
AAV
DMPK
Cell penetrating peptide
Exercise
Transcriptomics
Expression
ARN
Myostatin
Brain dysfunction
Myotonic Dystrophy type 1
Muscular dystrophy
Duchenne muscular dystrophy
Brain
Muscle
Neuron
Glucocorticoid-receptor
DM1
CTG repeat contractions
Skeletal muscle
Astrocyte
Male
Antisense oligonucleotides
Centronuclear myopathy
Myotonic dystrophy mouse models
Oligodendrocytes
Acetylcholinesterase knockout mouse
Dystrophin
Myotonic Dystrophy Type 1
CTG repeat instability
Central nervous system
Glucocorticoids
Humans
CTG repeats
Dystrophie Myotonique
Thérapie génique
Acute coronary syndrome
Mouse model
Myotonic dystrophy
Gene Therapy
Cell culture model
CMS
Dystrophie myotonique
Gene editing
Exercice
Mouse models
Myotonic dystrophy type 1
Cytoskeleton
Endurance training
Gene therapy
Quantitative microdialysis
PCR
Myelin
PacBio
RNA splicing
Fibrosis
Transgenic mouse model
Heart failure
Intermediate filament
Diaphragm
Maximal force
Heart
Genotype phenotype correlation
BIOLOGIE MOLECULAIRE
Alternative splicing
CRISPRi
Mice
Long read sequencing
Glutamate
Astrocytes
Cardiac muscle
KNOCKOUT MICE
Transgenic mouse
Trinucleotide repeat expansion
Desmin
Motoneuron
CONGENITAL MYATHENIC SYNDROME
Cell model
DMSXL mice
Dynamin 2
Oligodendrocyte
Autophagy
Myotonic Dystrophy
Trinucleotide Repeat Expansion
MBNL
GSK3
Glial cells
Acetylcholinesterase deficiency
In vivo
GABA
Animals
RNA interference
Knockout
Dilated cardiomyopathy
Therapy
Hypoxia
CRISPR/Cas9
ACETYLCHOLINESTERASE